A graphSAGE discovers synergistic combinations of Gefitinib, paclitaxel, and Icotinib for Lung adenocarcinoma management by targeting human genes and proteins: the RAIN protocol
Preprint in medRxiv (April 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis
Article in European Journal of Clinical Pharmacology (February 2024)
Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: a meta-analysis
Preprint in Research Square (October 2023)